Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alberto Zanella(University of Milan), Marta Lisa Battista, Francesco Zaja, Renato Fanin(University of Udine), Dario Consonni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Agostino Cortelezzi(University of Milan), Bruno Fattizzo(University of Milan), Anna Zaninoni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Eros Di Bona(San Antonio College), Francesca Guia Imperiali(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 144
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|737
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657